Print the page
Increase font size
Groundhog Day (Lockdown Edition)

Groundhog Day (Lockdown Edition)

Chris Campbell

Posted August 23, 2023

Chris Campbell

Alex Jones.

The name alone is enough to spark heated debates in homes and social circles across the nation.

It’s synonymous with conspiracy theories, fiery rhetoric, and a style of journalism that is unashamedly provocative.

When Jones speaks, people either seethe… or cheer… or run away… or tiptoe closer with feigned disinterest.

As usual, Jones has stirred the pot yet again…

Igniting a flurry of speculation on Musk's former bird app, X.

And… what if he’s right?

(Broken clocks. Blind squirrels. And all that.)

The Informant!

In case you missed it: 

According to Jones, a “high-level manager in the TSA,” risking much to break rank and step into the light, has confided in him.

The word from the informant? By the time the leaves turn and October graces us, travelers might find themselves once again ensnared in the tangled weave of face masks.

And…

As winter's icy grip approaches, and December takes hold, there may be a return to the all-too-familiar dance of restrictions and lockdowns.

Normally, we’d shrug it off. Claims of “secret whistleblowers” are a dime-a-dozen online.

But, the thing…

The media is indeed ramping up the rhetoric on lockdowns, booster shots, and masks.

To wit:

CNN Tweet

No less, major Hollywood studio Lionsgate… George Morris Brown College… Rutgers University… and more have already announced fresh new mandates.

What if we are in for another round of lockdowns?

Who stands to benefit? What are the paranoids doing to prepare?

And what’s the one “variant-proof” investment that should do well either way?

The Groundhog Day Portfolio

Let’s take a trip down memory lane.

As lockdowns halted travel, astute investors eyed put options on major oil companies, foreseeing a decline in oil demand.

Meanwhile, the heightened demand for personal protective equipment due to lockdowns increased the allure of stocks from key PPE manufacturers.

The global urgency for vaccination thrust pharmaceutical giants into the limelight, particularly as new COVID-19 variants emerged.

The year also marked a pivotal shift towards remote work and telehealth, with companies like Teladoc Health and Zoom becoming integral to this new normal.

But one investment on the “covid 2.0 watchlist” stands out.

By many accounts, it could be poised to succeed regardless.

It’s natural gas.

Extended winter lockdowns boosted the need for heating, favoring investments in natural gas entities. But a cold snap would do that regardless.

Also, since a lot of natural gas travels through the Panama Canal -- which is, of course, experiencing a drought -- that could also push prices up, too.

Should you believe the hype? That’s up to you.

But the point is to win no matter what.

The AI Babysitter Boom

Posted November 17, 2026

By James Altucher

10 ways to get paid.

OFFLINE: Email, Flights, Payroll, Banks

Posted November 16, 2026

By Chris Campbell

Rogue AI does it again… allegedly.

The World Didn’t End. Now What?

Posted November 13, 2026

By Chris Campbell

A scary story in three words.

Re: Re: Fwd: Is your email down?

Posted November 12, 2026

By Chris Campbell

Microsoft broke email. The businesses selling backup just got richer.

🔴🦢RED SWAN: Chinese Model Wrecks Nvidia

Posted November 11, 2026

By Chris Campbell

Two Huangs don’t make a right…

“I Made $336,025 on Micron. Here’s What I’m Buying Thursday”

Posted November 10, 2026

By James Altucher

From House Poor to 2,000% Gains.